MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, PPCB made $3,163,106 in revenue. -$4,031,486 in net income. Net profit margin of -127.45%.

Income Overview

Revenue
$3,163,106
Net Income
-$4,031,486
Net Profit Margin
-127.45%
EPS
-$0.3
Unit: Dollar
Revenue Breakdown
    • Administration expenses
    • Change in fair value of warrant ...
    • Change in fair value of derivati...
    • Others

Unit: Dollar
Income Statement
2025-12-31
2025-09-30
2025-06-30
2025-03-31
Tax benefit
--0 -
Administration expenses
3,628,173 4,598,574 3,585,351 53,068,147
Occupancy expenses - related party
6,600 14,789 6,373 6,469
Research and development
19,961 60,201 53,522 54,097
Total operating expenses
3,654,734 4,673,564 3,645,246 53,128,713
Loss from operations
-3,654,734 -4,673,564 -3,645,246 -53,128,713
Interest expense
58,955 305,649 254,542 104,042
Interest income
37 19 3.5 1
Derivative expense
--238,584 59,271
Change in fair value of derivative liabilities
87,728 -19,706 98,963 47,119
Change in fair value of warrant liability
-593,710 ---
Other expense
54,000 ---
Gain (loss) on extinguishment of debt, net
14,317 195,861 -31,000 -809,954
Foreign currency transaction gain (loss)
-19,497 -34,699 -1,059 -12,486
Total other income (expense), net
563,340 -164,174 -426,215 -938,633
Loss before taxes
-3,091,394 -4,837,738 -4,071,461 -54,067,346
Net Income Loss
-3,091,394 -4,837,738 -4,071,461 -54,067,346
Deemed dividend
932,246 -0 -
Net loss
-4,023,640 --4,071,461 -54,067,346
Unrealized foreign currency translation gain (loss)
-7,846 17,044 -145,640 -27,311
Total other comprehensive income (loss)
-7,846 17,044 -145,640 -27,311
Total comprehensive loss
-4,031,486 -4,820,694 -4,217,101 -54,094,657
Basic net loss per share
-0.3 -0.39 29.88 -12.5
Basic weighted average shares outstanding
13,360,358 12,331,526 -591,308,663 4,325,994
Diluted net loss per share
-0.3 -0.39 29.88 -12.5
Diluted weighted average shares outstanding
13,360,358 12,331,526 -591,308,663 4,325,994
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$4,031,486 Total othercomprehensive income (loss)-$7,846 Net loss-$4,023,640 Unrealized foreigncurrency translation...-$7,846 Deemed dividend$932,246 Net Income Loss-$3,091,394 Gain (loss) onextinguishment of debt, net$14,317 Change in fair value ofwarrant liability-$593,710 Change in fair value ofderivative liabilities$87,728 Interest income$37 Loss before taxes-$3,091,394 Total other income(expense), net$563,340 Foreign currencytransaction gain (loss)-$19,497 Other expense$54,000 Interest expense$58,955 Loss from operations-$3,654,734 Total operatingexpenses$3,654,734 Research and development$19,961 Occupancy expenses -related party$6,600 Administration expenses$3,628,173

Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma, Inc. (PPCB)